Fluoxetine Toxic Dose
Therapeutic range: Fluoxetine (Prozac) is typically dosed 20-80 mg/day. It's one of the safer antidepressants in overdose compared to older TCAs and MAOIs, largely because it has minimal cardiotoxicity and a wide therapeutic index - Kaplan and Sadock's Synopsis of Psychiatry notes it was "significantly safer when taken in overdose than any previously available antidepressant."
Reported toxicity thresholds:
| Population | Dose | Effect |
|---|
| Adults | Up to 300-400 mg | Maximum tolerated with no toxicity (no co-ingestant) |
| Adults | 1200-2000 mg | Estimated minimum lethal exposure range |
| Adults | ~520 mg (reported case) | Associated with a lethal outcome in at least one case, though survival after 8 g has also been documented - illustrating wide individual variability |
| Children | Up to 3.6 mg/kg | No toxicity observed |
| Children | ~9-19.5 mg/kg | Reported seizures in adolescent case series |
| Children | 26 mg/kg | Seizures and minor ECG changes reported |
| Children | 43 mg/kg | Unresponsiveness, sinus tachycardia, psychomotor agitation |
Serum levels (Harriet Lane Handbook): Levels >1000 ng/mL are considered toxic, though toxicity may occur at levels >300 ng/mL.
Clinical features of overdose (per Tintinalli's Emergency Medicine, which notes fluoxetine has the largest human SSRI overdose experience of any SSRI):
- Mild CNS depression, tremor, nausea/vomiting are most common with isolated SSRI overdose
- Seizures can occur, typically generalized, usually 3-8.5 hours post-ingestion in adolescent case reports
- Serotonin syndrome/toxicity (Sternbach criteria) - agitation, hyperreflexia, clonus, hyperthermia, autonomic instability
- QT/QRS prolongation and arrhythmia (including reported Torsades de Pointes) are rare but described, more often with large ingestions or co-ingestants
- Rhabdomyolysis has been reported with delayed onset
- Death from isolated fluoxetine overdose is rare and usually involves very large ingestions (multi-gram) or co-ingestants (e.g., benzodiazepines)
Key point: Fatal outcomes from fluoxetine alone are uncommon relative to older antidepressants - most fatalities reported in literature involve massive ingestions (>10 g) or combination with other CNS depressants/cardiotoxic drugs.
Management: Supportive care, activated charcoal if presenting early, cardiac monitoring/ECG for QT prolongation, benzodiazepines for seizures or agitation, and cyproheptadine for serotonin syndrome if it develops.
Recent case reports (PMID: 37957092, 30301727) reinforce that seizures and serotonin toxicity are the main concerns in adolescent overdoses even at moderate doses (600-1200 mg, ~10-20 mg/kg), and a case of fatal Torsades de Pointes (PMID: 30214811) shows cardiac risk isn't zero even though it's rare. These don't contradict the textbook consensus but add nuance - individual susceptibility varies significantly.
- Tintinalli's Emergency Medicine, p. (Clinical Features, SSRI overdose section)
- Kaplan and Sadock's Synopsis of Psychiatry (SSRIs section)
- The Harriet Lane Handbook, 23rd ed.